PETS Stock Overview
Operates as a pet pharmacy in the United States. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
PetMed Express, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$4.58 |
52 Week High | US$7.90 |
52 Week Low | US$2.90 |
Beta | 0.68 |
11 Month Change | 16.84% |
3 Month Change | 50.66% |
1 Year Change | -39.26% |
33 Year Change | -83.90% |
5 Year Change | -80.20% |
Change since IPO | 266.40% |
Recent News & Updates
PetMed Express: Why (And Why Not) The Rebound Could Continue
Nov 12Optimistic Investors Push PetMed Express, Inc. (NASDAQ:PETS) Shares Up 28% But Growth Is Lacking
Oct 04Recent updates
PetMed Express: Why (And Why Not) The Rebound Could Continue
Nov 12Optimistic Investors Push PetMed Express, Inc. (NASDAQ:PETS) Shares Up 28% But Growth Is Lacking
Oct 04PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Aug 09PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates
Jun 14PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price
Jun 12A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)
Oct 09PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30
Aug 07The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence
Mar 23PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Feb 10PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Nov 11PetMed Express Puts Are Compelling
Aug 25PetMed Express CFO to leave post today, by remain with company over transition period
Aug 02PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30
Jul 29PetMed Express FQ1 2023 Earnings Preview
Jul 24PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform
Jul 15Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture
Jul 04PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth
May 26PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30
May 13Shareholder Returns
PETS | US Specialty Retail | US Market | |
---|---|---|---|
7D | -13.2% | -0.1% | -1.2% |
1Y | -39.3% | 27.6% | 30.4% |
Return vs Industry: PETS underperformed the US Specialty Retail industry which returned 27.6% over the past year.
Return vs Market: PETS underperformed the US Market which returned 30.4% over the past year.
Price Volatility
PETS volatility | |
---|---|
PETS Average Weekly Movement | 12.0% |
Specialty Retail Industry Average Movement | 7.3% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.5% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PETS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PETS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 287 | Sandra Campos | www.1800petmeds.com |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PetMed Express, Inc. Fundamentals Summary
PETS fundamental statistics | |
---|---|
Market cap | US$93.47m |
Earnings (TTM) | -US$963.00k |
Revenue (TTM) | US$259.34m |
0.4x
P/S Ratio-98.1x
P/E RatioIs PETS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PETS income statement (TTM) | |
---|---|
Revenue | US$259.34m |
Cost of Revenue | US$188.00m |
Gross Profit | US$71.34m |
Other Expenses | US$72.31m |
Earnings | -US$963.00k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.047 |
Gross Margin | 27.51% |
Net Profit Margin | -0.37% |
Debt/Equity Ratio | 0% |
How did PETS perform over the long term?
See historical performance and comparison